Concepedia
Statistics
Publications
23
Citations
2.4K
H-Index
19
Active since
1990
Affiliations
University of Wisconsin–Madison(Current)
University of Chicago
University of Wisconsin Carbone Cancer Center
William S. Middleton Memorial Veterans Hospital
University of Wisconsin System
Russell F. Jacoby is an author at University of Wisconsin–Madison specializing in medicine, carcinogenesis, and colorectal cancer.
Publications per year
1990–2004
The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Russell F. Jacoby, Karen Seibert, Carolyn E. Cole et al. · PubMed · 2000 · 483 citations
Medicine, Pharmacology, Pharmacotherapy +14
MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability
Steven M. Lipkin, Victoria Wang, Russell F. Jacoby et al. · Nature Genetics · 2000 · 331 citations
Life Sciences, Genetics, Molecular Genetics +11
Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.
Russell F. Jacoby, D. J. Marshall, Michael A. Newton et al. · PubMed · 1996 · 295 citations
Medicine, Oncology, Pharmacology +13
Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status.
William F. Dove, Linda Clipson, Karen A. Gould et al. · PubMed · 1997 · 159 citations
Medicine, Microbiology, Oncology +17
Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
Russell F. Jacoby, Carolyn E. Cole, Kendra D. Tutsch et al. · PubMed · 2000 · 152 citations
1–5 of 23